Similar Articles
A retrospective review of antiphospholipid syndrome from a South Asian country
Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz
DOI: 10.46497/ArchRheumatol.2022.8979
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients
Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi
DOI: 10.46497/ArchRheumatol.2022.9217
Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
Hejun Li, Yiqing Zheng, Ling Chen, Shunping Lin
DOI: 10.46497/ArchRheumatol.2022.9366
The ABCs of antiphospholipid syndrome
Ayşe Bahar Keleşoğlu Dinçer, Doruk Erkan
DOI: 10.46497/ArchRheumatol.2023.41875
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
The first involved joints and associated factors in patients with rheumatoid arthritis
Mete Pekdiker, Hamdi Oğuzman
DOI: 10.46497/ArchRheumatol.2024.10417
Association of focus score and extraglandular involvement in Sjögren's syndrome: A study on antinuclear antibodies and minor salivary gland pathology
Mustafa Çağrı Ergün, Okancan Yılmaz, Hakan Bilgen, Pembe Oltulu, Fahriye Kılınç, Recep Tunç
DOI: 10.46497/ArchRheumatol.2024.10410